Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (141-150 of 263) with videos related to

Pageof 27
Sort By:
British Journal of Clinical Pharmacology|December 1, 1996
A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activityC Masimirembwa, I Persson, L Bertilsson, et al.
British Journal of Clinical Pharmacology|February 12, 1998
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapineB Eiermann, G Engel, I Johansson, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylationB Mellström, L Bertilsson, J Säwe, et al.
British Journal of Clinical Pharmacology|April 1, 1988
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquineM Eichelbaum, L Bertilsson, A Küpfer, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylationB Mellström, L Bertilsson, Y C Lou, et al.
Pharmacogenetics|December 1, 1996
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among EthiopiansI Persson, E Aklillu, F Rodrigues, et al.
Pharmacogenetics|December 1, 1995
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotypeM Chang, M L Dahl, G Tybring, et al.
Lancet (London, England)|May 16, 1981
Hydroxylation of debrisoquine in patients with lacticacidosis after phenforminB E Wiholm, G Alvan, L Bertilsson, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2000
Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disordersM Sagar, L Bertilsson, M Stridsberg, et al.
Archives of General Psychiatry|November 1, 1980
Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspectsP Thorén, M Asberg, L Bertilsson, et al.
Pageof 27

Showing results (141-150 of 263) with videos related to

Sort By:
Pageof 27
British Journal of Clinical Pharmacology|December 1, 1996
A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activityC Masimirembwa, I Persson, L Bertilsson, et al.
British Journal of Clinical Pharmacology|February 12, 1998
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapineB Eiermann, G Engel, I Johansson, et al.
Clinical Pharmacology and Therapeutics|August 1, 1981
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylationB Mellström, L Bertilsson, J Säwe, et al.
British Journal of Clinical Pharmacology|April 1, 1988
Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquineM Eichelbaum, L Bertilsson, A Küpfer, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylationB Mellström, L Bertilsson, Y C Lou, et al.
Pharmacogenetics|December 1, 1996
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among EthiopiansI Persson, E Aklillu, F Rodrigues, et al.
Pharmacogenetics|December 1, 1995
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotypeM Chang, M L Dahl, G Tybring, et al.
Lancet (London, England)|May 16, 1981
Hydroxylation of debrisoquine in patients with lacticacidosis after phenforminB E Wiholm, G Alvan, L Bertilsson, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2000
Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disordersM Sagar, L Bertilsson, M Stridsberg, et al.
Archives of General Psychiatry|November 1, 1980
Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspectsP Thorén, M Asberg, L Bertilsson, et al.
Pageof 27